 |
|
Bisphosphonate-induced Severe Hypocalcemia - A Case Report -
Won-Seok Do, Jin-Kyung Park, Myung-Il Park, Hyeong-Seok Kim, Sung-Ho Kim, Duk-Hyun Lee
J Bone Metab. 2012;19(2):139-145. Published online 2012 Nov 16 DOI: https://doi.org/10.11005/jbm.2012.19.2.139
|
|
Citations to this article as recorded by
 Herbal medicine Ninjinyoeito inhibits RANKL-induced osteoclast differentiation and bone resorption activity by regulating NF-κB and MAPK pathway
Kaung Htike, Kunihiro Yoshida, Takanori Eguchi, Katsuki Takebe, Xueming Li, Yaxin Qu, Eiko Sakai, Takayuki Tsukuba, Kuniaki Okamoto
Journal of Oral Biosciences.2024; 66(4): 49. CrossRef Discovery of PMSA Derivative 11 as a Novel Lead Compound for Therapeutic Treatment of Osteoporosis In Vitro and In Vivo
Zhihao Chen, Karthik Rajan Rajamanickam, Mina Ding, Sang Kyoon Kim, Sang-wook Park, Eunae Kim, Sunwoo Lee, Tae-Hoon Lee
Journal of Medicinal Chemistry.2023; 66(10): 6766. CrossRef Biochemical, clinical manifestation of vitamin D deficiency in calves
І. P. Ligomina, V. M. Sokolyuk, I. M. Sokulskyi, B. V. Gutyj, V. B. Dukhnytskyi
Ukrainian Journal of Veterinary and Agricultural Sciences.2023; 6(2): 68. CrossRef Non-biological Antiresorptive: Bisphosphonates
Durairaj Arjunan, Tushar Bhadada, Subasri B Mohankumar, Sanjay Kumar Bhadada
Indian Journal of Orthopaedics.2023; 57(S1): 120. CrossRef Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Danielle E Robinson, M Sanni Ali, Victoria Y Strauss, Leena Elhussein, Bo Abrahamsen, Nigel K Arden, Yoav Ben-Shlomo, Fergus Caskey, Cyrus Cooper, Daniel Dedman, Antonella Delmestri, Andrew Judge, Muhammad Kassim Javaid, Daniel Prieto-Alhambra
Health Technology Assessment.2021; 25(17): 1. CrossRef 2-NPPA Mitigates Osteoclastogenesis via Reducing TRAF6-Mediated c-fos Expression
Zhihao Chen, Mina Ding, Eunjin Cho, Jihyoun Seong, Sunwoo Lee, Tae-Hoon Lee
Frontiers in Pharmacology.2021;[Epub] CrossRef Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients
H. McKee, G. Ioannidis, A. Lau, D. Treleaven, A. Gangji, C. Ribic, M. Wong-Pack, A. Papaioannou, J. D. Adachi
Osteoporosis International.2020; 31(5): 973. CrossRef Trastornos electrolíticos inducidos por fármacos y sustancias tóxicas
Edna Chinchilla-Escobar, Héctor Pérez-Madrid, Laura Jiménez-Ospina, Diana Cabrera-Rojas, Natalia Palacín-Bernal, Germán Sepúlveda-Barbosa, Juan D. Piedrahita-Pérez, Luisa F. Díaz-Vélez, Juliana Quintero-Aguirre, María A. Montoya-Giraldo
Medicina y Laboratorio.2020; 25(1): 363. CrossRef Prolonged use of alendronate alters the biology of cranial repair in estrogen-deficient rats’ associated simultaneous immunohistochemical expression of TGF-β1+, α-ER+, and BMPR1B-
Allan Fernando Giovanini, Giuliene Nunes de Sousa Passoni, Isabella Göhringer, Tatiana Miranda Deliberador, João Cesar Zielak, Carmem Lucia Muller Storrer, Thais Andrade Costa - Casagrande, Rafaela Scariot
Clinical Oral Investigations.2018; 22(5): 1959. CrossRef Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with153Sm-EDTMP
Eva Kassi, Ifigeneia Kapsali, Michalis Kokkinos, Helen Gogas
BMJ Case Reports.2017; : bcr-2017-219354. CrossRef Osteoprotective therapy with bisphosphonates or denosumab in patients with multiple myeloma: benefit and risks
Zdeněk Adam, Jan Straub, Marta Krejčí, Luděk Pour, Dagmar Brančíková, Lenka Ostřížková, Viera Sandecká, Martin Štork
Vnitřní lékařství.2017; 63(5): 311. CrossRef
|